Stock JYNT THE JOINT CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Joint Corp.

Equities

JYNT

US47973J1025

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-06 pm EDT 		5-day change 1st Jan Change
15.79 USD -2.05% Intraday chart for The Joint Corp. +28.17% +64.31%
May. 06 B. Riley Adjusts Price Target on Joint to $20 From $12, Maintains Buy Rating MT
May. 02 Transcript : The Joint Corp., Q1 2024 Earnings Call, May 02, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 223.8 368.7 946.8 203.1 141.8 236.4 - -
Enterprise Value (EV) 1 215.4 353.1 929.4 195.4 141.8 236.4 236.4 236.4
P/E ratio 70.2 x 29.2 x 137 x 175 x -14.6 x 188 x 33.2 x 28.2 x
Yield - - - - - - - -
Capitalization / Revenue 4.62 x 6.28 x 11.7 x 1.99 x 1.2 x 2.07 x 2.33 x 2.93 x
EV / Revenue 4.62 x 6.28 x 11.7 x 1.99 x 1.2 x 2.07 x 2.33 x 2.93 x
EV / EBITDA 36.1 x 40.5 x 71.4 x 17.6 x 11.6 x 21.7 x 13.8 x 14.2 x
EV / FCF 55.1 x 45.9 x 115 x 39.2 x 14.6 x 17.8 x 19.6 x 26.1 x
FCF Yield 1.81% 2.18% 0.87% 2.55% 6.83% 5.63% 5.1% 3.84%
Price to Book 40.8 x 17.9 x 32.1 x 6.26 x 5.73 x 9.18 x 7.08 x 5.83 x
Nbr of stocks (in thousands) 13,863 14,041 14,413 14,530 14,754 14,974 - -
Reference price 2 16.14 26.26 65.69 13.98 9.610 15.79 15.79 15.79
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 48.45 58.68 81.19 101.9 117.7 114.1 101.5 80.58
EBITDA 1 6.196 9.103 13.25 11.52 12.21 10.87 17.12 16.66
EBIT 1 3.415 5.492 6.009 2.077 -2.073 1.95 9.132 11.75
Operating Margin 7.05% 9.36% 7.4% 2.04% -1.76% 1.71% 9% 14.58%
Earnings before Tax (EBT) 1 3.372 5.413 5.939 1.944 1.639 2.051 9.132 11.75
Net income 1 3.324 13.17 7.159 1.177 -9.752 1.274 7.313 9.281
Net margin 6.86% 22.44% 8.82% 1.16% -8.29% 1.12% 7.21% 11.52%
EPS 2 0.2300 0.9000 0.4800 0.0800 -0.6600 0.0840 0.4750 0.5600
Free Cash Flow 1 4.058 8.027 8.243 5.186 9.679 13.3 12.06 9.07
FCF margin 8.37% 13.68% 10.15% 5.09% 8.22% 11.65% 11.89% 11.26%
FCF Conversion (EBITDA) 65.49% 88.18% 62.19% 45.03% 79.29% 122.3% 70.45% 54.44%
FCF Conversion (Net income) 122.08% 60.96% 115.14% 440.48% - 1,043.79% 164.95% 97.73%
Dividend per Share - - - - - - - -
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 22.43 22.44 25.06 26.6 27.81 28.45 29.31 29.47 30.61 29.72 29.4 27.83 27.17 24 23.65
EBITDA 1 2.741 1.783 2.635 3.129 3.968 2.035 3.232 2.897 4.041 3.507 2.318 2.571 2.856 3.8 4.6
EBIT 1 0.6632 -0.1764 0.4732 0.5005 1.28 -0.6782 -0.3746 -0.898 -0.1474 1.09 -0.1515 0.4655 0.6962 1.45 2.4
Operating Margin 2.96% -0.79% 1.89% 1.88% 4.6% -2.38% -1.28% -3.05% -0.48% 3.67% -0.52% 1.67% 2.56% 6.04% 10.15%
Earnings before Tax (EBT) 1 0.6474 -0.1926 0.4539 0.4752 1.207 3.143 -0.4811 -0.9043 -0.1439 1.126 -0.1702 0.4468 0.6812 1.45 2.4
Net income 1 0.2236 -0.2058 0.3447 0.4911 0.5472 2.301 -0.1904 -0.7163 -11.04 0.947 -0.2185 0.2235 0.4218 1.15 1.95
Net margin 1% -0.92% 1.38% 1.85% 1.97% 8.09% -0.65% -2.43% -36.07% 3.19% -0.74% 0.8% 1.55% 4.79% 8.25%
EPS 2 0.0100 -0.0100 0.0200 0.0300 0.0400 0.1500 -0.0100 -0.0500 -0.7500 0.0600 -0.0125 0.0150 0.0280 0.0750 0.1250
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/24/22 5/5/22 8/4/22 11/3/22 3/9/23 5/4/23 9/13/23 11/9/23 3/7/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 8.4 15.6 17.4 7.75 - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 4.06 8.03 8.24 5.19 9.68 13.3 12.1 9.07
ROE (net income / shareholders' equity) 103% 99.5% 28.6% 3.8% - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 0.4000 1.470 2.050 2.230 1.680 1.720 2.230 2.710
Cash Flow per Share - - - - - - - -
Capex 1 3.48 3.16 6.99 5.9 5 3.27 1.8 1.8
Capex / Sales 7.19% 5.38% 8.61% 5.79% 4.25% 2.87% 1.77% 2.23%
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for The Joint Corp.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
15.79 USD
Average target price
15.38 USD
Spread / Average Target
-2.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
THE JOINT CORP. Stock The Joint Corp.
+64.31% 238M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.55% 80.61B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.12% 70.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.76% 29.12B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.55% 16.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.71% 16.96B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-1.62% 15.26B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.35% 12.41B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.88% 11.95B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-5.39% 11.93B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. JYNT Stock
  4. Financials The Joint Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW